-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Capital Markets Downgrades Sutro Biopharma to Market Perform

Benzinga·03/14/2025 15:30:25
Listen to the news
Citizens Capital Markets analyst Reni Benjamin downgrades Sutro Biopharma (NASDAQ:STRO) from Market Outperform to Market Perform.